May 9, 2007 — Biosense Webster today announced commercial availability of its EZ Steer NAV Bi-Directional Catheter, indicated for use with the Carto XP System, a unique navigational system that provides real-time feedback in guiding the catheter to the target.

The defining feature of the new bi-directional navigational catheter is its patented micro-tensioning system, which enables physicians, through a series of very small, continuous micro-movements, to progressively dial in the precise force desired for deflection of the catheter.

May 9, 2007 — Biosense Webster Inc., a worldwide leader in cardiac mapping and ablation, and Medtronic Inc., world leader in implanted cardiac rhythm devices, have announced plans to collaborate on a clinical trial, educational initiatives and a product development program, all of which are aimed at advancing the care of patients with cardiac arrhythmias, also known as irregular heartbeats.

May 9, 2007 — Allied Minds, an investment corporation specializing in early stage university business ventures, has teamed with the University of Colorado to establish Illumasonix LLC, a start-up company that is developing a noninvasive method to provide quantitative information on complex blood flow in the treatment of vascular disease.

May 9, 2007 — Edwards Lifesciences Corp., a global developer of heart valves, has announced the first clinical study results of the recently introduced Edwards Myxo ETlogix annuloplasty ring. The study results showed that the ring, designed specifically to treat patients with myxomatous disease, reduced mitral regurgitation (MR) in patients who underwent the surgery to repair their diseased mitral valves.

May 9 — Brookwood Pharmaceuticals, Inc. and Targeted Technology Ventures LLC have announced the creation of a collaborative joint venture — Aeon Bioscience, Inc. — a company that will work to develop a new drug-eluting stent to overcome the current concerns of late stent thrombosis (LST) or blood clot formation at or near the site of the stent and vessel closure due to formation of scar tissue, known as restenosis.

The TURBO elite product line for excimer laser ablation is comercially available to treat peripheral artery disease (PAD). The line features an enhanced outer jacket and inner guide wire lumen with optimized ablation efficiency and energy output that enables increased penetration rates.

St. Jude Medical Inc. has announced FDA clearance for its Venture Wire Control Catheter on a rapid exchange delivery platform, a delivery design that accommodates shorter guide wires and may result in quicker, easier coronary procedures.

CardioMEMS Inc. received FDA clearance of its EndoSure AAA Wireless Pressure Measurement System for measuring intrasac pressure during thoracic aortic aneurysm (TAA) repair. The system is comprised of an implanted sensor and an external electronics module.

Cordis Corp. recently introduced the REGATTA Steerable Guidewire family of devices in the U.S., which 12 selections of the REGATTA Steerable Guidewire and two choices of the REGATTA SB Steerable Guidewire. In April, the company plans to add the REGATTA HS Steerable Guidewire in two selections.

Horizon Cardiology is a complete cardiovascular information solution for cath, hemodynamic monitoring, echocardiography, vascular ultrasound and nuclear cardiology. It meets a variety of needs for healthcare organizations with diagnostic digital image management, archiving, procedure reporting and workflow management.

Version 11.2 was introduced during the American College of Cardiology, which features total Web accessibility and many enhanced features.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now